Morphology and minimum ADC would be useful in distinguishing breast cancer subtypes.
Introduction
It has become generally accepted concept to regard breast cancer as a group of heterogeneous diseases rather than a single disease 1 . Using an immunohistochemical examination of the amounts of estrogen receptor (ER), progesterone receptor (PgR), human epidermal growth factor receptor 2 (HER2), and Ki-67 expression which reflects cellular proliferation, breast cancers are classified into several subtypes 1 . Breast cancer subtypes have different clinical features, including different prognoses and responses to therapies [1] [2] [3] [4] [5] . Therefore, non-invasive prediction of subtype using magnetic resonance imaging (MRI) is a desirable approach for selecting therapies.
Several reports have compared diffusion weighted imaging (DWI) and apparent diffusion coefficient (ADC) values in addition to the morphological characteristics on MRI with various pathological findings and biomarkers of breast cancer [6] [7] [8] [9] [10] [11] . The ADC reflects the microenvironment of the tissue structures and is therefore related to the malignant features, such as cellularity, of the tumor. Most of the studies used mean ADC 6, 9 ; however, the usefulness of minimum (min) ADC, which may reflect the most malignant portions of the tumor, in differentiating between malignant and benign breast masses and in detecting an invasive component in ductal carcinoma in situ has recently been reported 12, 13 . Additionally, ADC might reflect other characteristics of tissue structures, such as the amount of fibrous stroma and the pg. 4 degree of cellular proliferation or nuclear atypia. Therefore, we hypothesized that the min ADC might be related to the breast cancer subtypes or biomarkers, too.
In addition to various subtypes, triple-negative (TN) breast cancer has heterogeneity; both invasive ductal carcinomas, which tend to exhibit low differentiation and poor prognosis, and special type breast cancers such as adenoid cystic carcinoma and medullary carcinoma, which tend to have relatively good prognosis, are included 1, 14 . Therefore, differentiation of these two subgroups, in addition to subtype, is also important. In addition to tumor cellularity, the ADC possibly reflects the microstructural characteristics-such as tubules, pseudocysts, and matrices-that can exist in several special types of cancers. Therefore, we considered that the min ADC might have the potential to distinguish between invasive ductal carcinomas and special types in TN breast cancers, reflecting their different histopathology.
The purposes of this study are (1) to compare morphological features and min ADC values among breast cancer subtypes, including TN cancer subgroups, and (2) to investigate the correlation between the Ki-67 index and min ADC in comparison with mean ADC values.
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Materials and Methods
This retrospective study was approved by our institutional review board, and informed consent was waived. From February 2012 to June 2013, 95 consecutive patients who underwent breast MRI at 3-tesla (T) before operation without chemotherapy and hormonal therapy and had pathologically proven invasive carcinoma in operation specimens were studied. Two patients were excluded because of the difficulty in detecting the tumor on MRI; one had a small lesion with a large hematoma after biopsy in the breast, and another had marked background enhancement. Therefore, 93 patients were enrolled in this study. The median age was 60 years (range: 32-84 years), and all patients were women. The median interval between MR examination and operation was 29 days (range: 7-153).
There were 98 invasive carcinomas in 93 patients; three patients had bilateral breast carcinomas and two patients had two independent unilateral breast carcinomas. Independent unilateral cancers were considered when the pathological diagnosis or the ER, PgR, and HER2 receptor status of these cancers were different. The 98 lesions consisted of 80 invasive ductal carcinomas, 8 invasive lobular carcinomas, 2 invasive apocrine carcinomas, 2 tubular carcinomas, 2 metaplastic carcinomas, 1 adenocarcinoma, 1 invasive micropapillary carcinoma, pg. 8 
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Image analysis
Morphological evaluation
MR images were reviewed retrospectively by a board-certified radiologist specializing in breast MR imaging with 13 years of experience, without knowledge of the pathological findings other than invasive breast cancer. Both axial dynamic scans and sagittal high resolution scans were used for evaluation. For mass lesions, the shape, margin and internal enhancement characteristics were evaluated; and for non-mass lesions, the distribution and internal enhancement patterns were evaluated, based on the findings of Breast Imaging Reporting and Data System MRI 15 .
ADC measurement
The ADC values of each lesion were measured by placing regions of interest (ROIs) within the targeted lesion on ADC maps. An oval-shaped ROI was placed inside the lesion, and made as large as possible while avoiding cystic or necrotic and hemorrhagic areas and obvious artifacts. When the lesion had both invasive and non-invasive components on the pathological pg. 10
Statistical Analysis
The tumor morphology on MRI was compared statistically among the subtypes using a 
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Results
There were 84 (85.7%) masses and 14 (14.3%) non-mass enhancements on MRI.
There was no significant difference in morphology (mass or non-mass) among subtypes ( Table   1 ). In the 84 masses, there were significant differences in shape, margin, and internal enhancement characteristics among subtypes (Table 2) , and in the 14 non-mass lesions, there were no significant differences among subtypes ( TNs are shown in Figure 2 and 3, respectively.
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Discussion
The present study demonstrated that there were differences in min ADC as well as morphological characteristics among breast cancer subtypes. Luminal A breast cancer tended to show a spiculated margin without rim enhancement and had significantly higher min ADC values than Luminal B (HER2-negative). TN breast cancer tended to show an oval/round shape with rim enhancement and exhibited significant differences in min ADC value between TN-ductal and TN-special. There were no significant findings for HER2-positive breast cancer.
A spiculated margin has been reported to be associated with low histological grade and low expression of Ki-67 (< 20%), while rim enhancement is associated with high histological grade and negative expression of ER and PgR
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. Our results showing that Luminal A breast cancer tended to have a spiculated mass margin without rim enhancement were consistent with those previous reports. We also found that a spiculated margin was rarely seen in ER-negative cancers, indicating that a spiculated margin would be a major finding for distinguishing between ER-positive and ER-negative cancers.
Previous studies have reported that there was no significant correlation between ADC and Ki-67 10, 11 . In our study, a weak but statistically significant correlation was observed between min ADC and Ki-67, especially in the Luminal (HER2-negative) subgroup. A correlation between ADC values and Ki-67 indexes was statistically significant both for min and pg. 15 mean ADC; however, the correlation was better in min ADC than mean ADC. Most of the previous studies used mean ADC, which is the conventional method, but we demonstrated that min ADC had a better result in the correlation with Ki-67. Min ADC of Luminal A was significantly higher than that of Luminal B (HER2-negative), which reflects the difference of Ki-67 expression between Luminal A and Luminal B (HER2-negative). Therefore, a higher min ADC indicated Luminal A. According to our ROC analysis, Luminal A cancer could be distinguished from Luminal B (HER2 negative) with high specificity (96%).
In our multivariate analysis, internal enhancement characteristic of the mass and min ADC were significant in distinguishing Luminal A from Luminal B (HER2-negative). The AUC (0.746) of this model was higher than that (0.672) from the ROC analysis using the min ADC only. Combining the morphological and min ADC data could be more useful regarding predicting Luminal A.
It has been reported that TN breast cancers tend to have a round/oval mass shape 6 and have rim enhancement 6, 7 . Thus our results showing that TN breast cancers showed round/oval mass shape significantly more often than the other subtypes and had rim enhancement were consistent with those previous reports. In the present study, we divided TN cancers into two subgroups, TN-ductal and TN-special, because of the clinico-pathologic heterogeneity in TN cancers. There was no difference in morphological features between TN-ductal and TN-special;
pg. 16 most TN masses showed oval/round shape (100% in TN-ductal and 80% in TN-special), none of the TN-ductal or TN-special masses exhibited a spiculated margin, and most TN masses showed rim enhancement (83.3％ in TN-ductal and 80％ in TN-special) ( Table 2 ). However, there was a significant difference in the min ADC value between them: the min ADC of TN-ductal was significantly lower than that of TN-special. Therefore the min ADC value could be used to distinguish between the ductal and special type of TN cancers. According to Youk et al., the ADC value of TN breast cancers (including both TN-ductal and TN-special) was higher than those for ER-positive and HER2-positive breast cancers 6 . In contrast, only TN-special cancer had a significantly higher min ADC than HER2-positive cancers in our study. If the heterogeneity of TN cancers is not considered and both TN-ductal and TN-special are treated as one group of TN cancers as in the previous report, the ADC value would change depending on the incidence of TN-ductal and TN-special in the study population.
In our study, TN-ductal had the lowest min ADC value among all subtypes. Because It has been reported in previous studies that min ADC is useful for differentiating between malignant and benign breast masses or for detecting an invasive component in ductal carcinoma in situ 12, 13 . In the present study, we used the min ADC value to differentiate among breast cancer subtypes, and showed significant differences in several subtypes. However, there is a slight difference in the definition of min ADC between the above-mentioned previous studies on breast MRI and our own study; in the previous studies the min ADC was the lowest mean ADC value among multiple small ROIs placed within the targeted lesion 12, 13 , whereas in our study the min ADC was the lowest value in the single ROI within the targeted lesion. The definition of our min ADC is commonly used [18] [19] [20] . The single ROI method might be more affected by outliers than the multiple ROI method; however, the single ROI method is feasible in clinical settings. When the ROIs were placed, we avoided cystic, necrotic, and hemorrhagic areas, as well as visual artifacts-which are possible causes of outliers-within the lesion.
In our study, more than half of the cancers were examined via MRI after biopsy.
According to Latifoltojar et al., the ADC values of the prostate at 1, 2, and 6 months post biopsy were not significantly different from the pre-biopsy values 21 . Therefore, we assumed that biopsy did not have a very significant effect on ADC measurement. In addition, we avoided placing ROI in hemorrhagic areas.
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There are several limitations to the present study. First, the study was retrospective and carried all the inherent limitations of retrospective investigations. Further prospective studies are needed to evaluate diagnostic performances of min ADC for differentiating tumor subtypes. Second, patients with chemotherapy or hormonal therapy before operation were not included in the present study. Therefore the numbers of TN and HER2-positive tumors were small, because patients with TN and HER2-positive tumors tend to receive neo-adjuvant chemotherapy. Third, for each tumor, we placed the ROI to measure the min ADC value on only one slice. We might have missed the most malignant portion in our single slice ROI measurement. If we had measured all the slices to find out the actual min ADC throughout the tumor, the results might be better. Fourth, the measurement positions between the min ADC value on MRI and the Ki-67 index in pathological specimens were different. We investigated the correlation between the ADC value and the Ki-67 index. The correlation should ideally be analyzed in the same position; however, it is difficult to completely match the position on MR images and pathological specimens in a factual manner. pg. 22 pg. 25 HER2 human epidermal growth factor receptor 2, TN triple-negative 
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Conclusion
